A new study published in the November issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS), has identified a significant clinical correlation that may reshape preoperative protocols for body contouring procedures. Researchers have found that patients who have previously contracted COVID-19 may face a heightened risk of venous thromboembolism (VTE)—a serious, potentially life-threatening condition involving the formation of blood clots—following panniculectomy.
This finding suggests that the physiological footprint of the SARS-CoV-2 virus extends well into the recovery period for elective and reconstructive surgeries, prompting surgeons to reconsider how they assess risk for patients undergoing abdominal skin removal.
Understanding the Procedure: What is a Panniculectomy?
To understand the gravity of these findings, it is essential to distinguish between cosmetic body contouring and a panniculectomy. While often categorized under the umbrella of plastic surgery, a panniculectomy is primarily a functional, reconstructive procedure. It is designed to remove the "panniculus"—a heavy, hanging apron of excess skin and subcutaneous fat from the lower abdomen that often remains after significant weight loss or bariatric surgery.
For many patients, this overhanging tissue is not merely a matter of aesthetics; it acts as a site for chronic rashes, debilitating skin infections, persistent ulcers, and severe mobility issues. By removing this tissue, surgeons provide patients with relief from recurring health complications, significantly improving their quality of life. However, like all major surgeries involving significant tissue manipulation, it carries inherent risks, with VTE being among the most scrutinized postoperative complications.
The Chronology of the Study: Tracking Post-Pandemic Trends
The research team, led by Mary Newland, BS, a medical student at Penn State College of Medicine in Hershey, Pennsylvania, conducted a comprehensive retrospective analysis of national hospital data. Their objective was to determine if the landscape of postoperative complications had shifted in the wake of the COVID-19 pandemic.
The study period spanned from 2017 to 2023, encompassing a total of 7,114 patients who underwent functional panniculectomy. The researchers divided the cohort into two primary groups to capture the impact of the pandemic:
- The Pre-Pandemic Group: Comprised of 3,015 patients who underwent surgery prior to the onset of the pandemic.
- The Post-Pandemic Group: Comprised of 4,099 patients who underwent surgery after March 2020.
Initially, the data showed a surprising level of consistency. The rate of VTE for the pre-pandemic group was 3.2%, while the post-pandemic group sat at 3.0%. On the surface, it appeared that the surgical environment had remained stable. However, as the researchers dove deeper into the post-pandemic cohort, the data revealed a striking disparity that had been masked by the larger sample size.
Supporting Data: The COVID-19 Connection
The granular analysis of the 4,099 post-pandemic patients yielded the most critical findings of the study. The researchers segmented this group based on their medical history regarding COVID-19:
- The COVID-History Subgroup: 790 patients who had a documented history of COVID-19 infection.
- The Non-COVID Subgroup: 3,309 patients who had no record of a prior COVID-19 infection.
When comparing these two groups, the incidence of VTE was statistically significant. Patients with a history of COVID-19 experienced a 4.9% rate of VTE, compared to just 2.5% among those who had not contracted the virus.
Crucially, the researchers controlled for other known variables that typically influence VTE risk, such as pre-existing heart disease, lung conditions, and vascular disease. Because these underlying risk factors were similar between both the COVID and non-COVID groups, the researchers concluded that the history of COVID-19 itself serves as an independent, predisposing risk factor for blood clots in the postoperative setting.
The Physiological Mechanism: Why COVID-19?
The medical community has long recognized that COVID-19 is not merely a respiratory disease; it is a systemic condition that significantly impacts the vascular and circulatory systems. The researchers suggest that the increased VTE risk observed in their study is likely linked to "hypercoagulability"—a state where the blood has an increased tendency to form clots.
In the aftermath of a COVID-19 infection, the body may experience lingering inflammation and endothelial dysfunction (damage to the lining of the blood vessels). When these patients undergo a major procedure like a panniculectomy, the surgical trauma triggers the body’s natural clotting response. In a patient whose blood is already primed for hypercoagulation due to the lasting effects of a prior COVID infection, this response can tip the scale, leading to the formation of deep vein thrombosis (DVT) or pulmonary embolism (PE).
Official Responses and Clinical Implications
Lead author Mary Newland emphasizes that these results necessitate a shift in how plastic surgeons prepare their patients. "Our findings suggest that past COVID may be an additional predisposing risk factor for VTE among patients undergoing panniculectomy," Newland stated. "This may have implications for assessment and prevention of surgical risks of body contouring surgery after major weight loss."
Currently, surgeons rely on the "Caprini score"—a standardized clinical tool used to assess a patient’s risk of developing VTE—to determine the necessity of prophylactic anticoagulants (blood thinners). The findings of this study suggest that a history of COVID-19 should potentially be integrated into these risk-assessment models.
If a patient’s history of COVID-19 is officially recognized as a risk factor, it could lead to:
- Enhanced Prophylaxis: More aggressive use of anticoagulants for patients with a recent or even remote history of COVID-19.
- Modified Preoperative Screening: Incorporating blood chemistry panels that specifically look for markers of residual hypercoagulability.
- Informed Consent: Surgeons may need to adjust their preoperative counseling to explicitly inform patients that a history of COVID-19 could influence their postoperative recovery timeline and risk profile.
The Call for Future Research
While this study provides compelling evidence of a link between COVID-19 history and VTE, the authors acknowledge that it is a starting point rather than a final conclusion. The medical field is only beginning to understand the "long-tail" effects of the pandemic on elective surgery outcomes.
The researchers emphasize that further, prospective studies are required to confirm these associations and to determine the duration for which a past COVID infection continues to elevate VTE risk. Is the risk higher for those who had the infection within the last six months? Does the severity of the initial COVID infection correlate with the level of VTE risk post-surgery? These are questions that will define the next phase of research in reconstructive plastic surgery.
Conclusion: A New Era of Surgical Vigilance
The study published in Plastic and Reconstructive Surgery® serves as a critical reminder that the pandemic’s impact on healthcare is ongoing. For surgeons performing panniculectomies, the focus must now shift to include a more nuanced understanding of the patient’s viral history.
By identifying this new "patient population" that may be more susceptible to postoperative complications, the medical community can move toward a more personalized approach to risk management. As patient safety remains the paramount objective in plastic and reconstructive surgery, integrating these findings into clinical practice will be essential to ensuring that the life-changing benefits of body contouring procedures are balanced with the highest standards of safety and preventative care.
For more information on the study, "Incidence of Postoperative Venous Thromboembolism following Panniculectomy in Patients with History of COVID-19" (doi: 10.1097/PRS.0000000000012202), readers are encouraged to visit the official website of Plastic and Reconstructive Surgery®.
About the Publisher
Plastic and Reconstructive Surgery® is the official journal of the American Society of Plastic Surgeons and is published in the Lippincott portfolio by Wolters Kluwer. Wolters Kluwer (EURONEXT: WKL) is a global leader in professional information, software solutions, and services for the healthcare, tax, and accounting sectors. Serving customers in over 180 countries, the organization continues to provide the data-driven insights necessary for medical professionals to navigate the complexities of modern clinical practice.
About the Author
